89 related articles for article (PubMed ID: 4151761)
21. Single daily doses of neuroleptic drugs.
Brophy JJ
Dis Nerv Syst; 1969 Feb; 30(2):120-3. PubMed ID: 5774571
[No Abstract] [Full Text] [Related]
22. Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. II. Structural requirements for D-amino acid oxidase inhibition.
Gabay S; Harris SR
Biochem Pharmacol; 1966 Mar; 15(3):317-22. PubMed ID: 4380375
[No Abstract] [Full Text] [Related]
23. Distribution and metabolism of chlorphentermine-C14 in rats and mice.
Dubnick B; Towne CA; Hartigan JM; Phillips GE
Biochem Pharmacol; 1968 Jul; 17(7):1243-50. PubMed ID: 4873073
[No Abstract] [Full Text] [Related]
24. Metabolism of 3-(2-dimethylaminoethyl)benzo(b)thiophene in vitro and in vivo in the rat.
Harrison SD; Bosin TR; Maickel RP
Drug Metab Dispos; 1974; 2(3):228-36. PubMed ID: 4152961
[No Abstract] [Full Text] [Related]
25. N-(2-(diethylamino)ethyl)-2-(p-hydroxyphenoxy)-acetamide, a metabolite of mefexamide in man.
Forist AA; Pulliam AL
Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):385-8. PubMed ID: 4853310
[No Abstract] [Full Text] [Related]
26. Identification and quantitative determination of phenothiazine drugs in urine samples of psychiatric patients.
De Leenheer AP
J Pharm Sci; 1974 Mar; 63(3):389-94. PubMed ID: 4150661
[No Abstract] [Full Text] [Related]
27. [A cyamepromazine-trifluoperazine combination: changes in metabolism during chronic administration in the rat].
Gaillot J; Bieder A; Ghaye Roquet J; Le Liboux A; Mazeau L
Therapie; 1975; 30(2):267-76. PubMed ID: 240218
[No Abstract] [Full Text] [Related]
28. Total excretion of 3H-chlorpromazine and 3H-prochlorperazine in chronically dosed animals: balance sheet.
Forrest IS; Fox J; Green DE; Melikian AP; Serra MT
Adv Biochem Psychopharmacol; 1974; 9(0):347-56. PubMed ID: 4836211
[No Abstract] [Full Text] [Related]
29. Determination by microcoulometric gas chromatography of chlorpromazine metabolites in human urine.
Johnson DE; Rodriguez CF; Burchfield HP
Biochem Pharmacol; 1965 Oct; 14(10):1453-69. PubMed ID: 5865871
[No Abstract] [Full Text] [Related]
30. Assay procedures for thioridazine, trifluoperazine, and their sulfoxides and determination of urinary excretion of these compounds in mental patients.
West NR; Rosenblum MP; Sprince H; Gold S; Boehme DH; Vogel WH
J Pharm Sci; 1974 Mar; 63(3):417-20. PubMed ID: 4820374
[No Abstract] [Full Text] [Related]
31. Disposition and metabolism of timiperone in the rat, dog, and monkey.
Tachizawa H; Sudo K; Sasano H; Sano M
Drug Metab Dispos; 1981; 9(5):442-8. PubMed ID: 6117443
[TBL] [Abstract][Full Text] [Related]
32. Orally active inhibitors of human leukocyte elastase. III. Identification and characterization of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometry.
Luffer-Atlas D; Vincent SH; Painter SK; Arison BH; Stearns RA; Chiu SH
Drug Metab Dispos; 1997 Aug; 25(8):940-52. PubMed ID: 9280402
[TBL] [Abstract][Full Text] [Related]
33. New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.
Staack RF; Fritschi G; Maurer HH
J Mass Spectrom; 2003 Sep; 38(9):971-81. PubMed ID: 14505325
[TBL] [Abstract][Full Text] [Related]
34. Determination of fluphenazine, related phenothiazine drugs and metabolites by combined high-performance liquid chromatography and radioimmunoassay.
Goldstein SA; Van Vunakis H
J Pharmacol Exp Ther; 1981 Apr; 217(1):36-43. PubMed ID: 6110775
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacobiochemistry of the coronary agent N,N'-bis(3-(3',4',5'-trimethoxy-benzoyloxy)-propyl)-homopiperazine(dihydrochloride-monohydrate)].
Schriewer H; Rauen HM
Arzneimittelforschung; 1972 Sep; 22(9):1455-9. PubMed ID: 4678606
[No Abstract] [Full Text] [Related]
36. [On the metabolism of eprazinone (author's transl)].
Toffel-Nadolny P; Gielsdorf W
Arzneimittelforschung; 1981; 31(4):719-22. PubMed ID: 7195719
[TBL] [Abstract][Full Text] [Related]
37. [Gas chromatographic method for the quantitative determination of ftoratsizin and its N-dealkylated metabolites in animal and human biological material].
Zherdev VP; Ekonomov AL; Vikhliaev IuI
Farmakol Toksikol; 1980; 43(2):215-8. PubMed ID: 6108236
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
Mutlib AE; Jurcak J; Hrib N
Drug Metab Dispos; 1996 Oct; 24(10):1139-50. PubMed ID: 8894517
[TBL] [Abstract][Full Text] [Related]
39. Basic metabolites of trazodone in humans.
Baiocchi L; Frigerio A; Giannangeli M; Palazzo G
Arzneimittelforschung; 1974 Oct; 24(10):1699-706. PubMed ID: 4479783
[No Abstract] [Full Text] [Related]
40. A cumulating metabolite derived from a piperazine-substituted phenothiazine drug.
Breyer U; Krauss D; Jochims CJ
Experientia; 1972 Mar; 28(3):312-3. PubMed ID: 5026447
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
